Հակահիստամինային դեղեր (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Հակահիստամինային դեղեր" in Armenian language version.

refsWebsite

Global rank Armenian rank

16nih.gov

4^th place

3^rd place

11doi.org

2^nd place

4^th place

2web.archive.org

1^st place

2aspetjournals.org

6,663^rd place

4,464^th place

1consumerhealthchoices.org

low place

737^th place

1guidetopharmacology.org

low place

3,289^th place

1archive.org

6^th place

1drugs.com

399^th place

102^nd place

archive.org

Norrby K (1995). «Evidence of a dual role of endogenous histamine in angiogenesis». Int J Exp Pathol. 76 (2): 87–92. PMC 1997159. PMID 7540412.

aspetjournals.org

jpet.aspetjournals.org

Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005 թ․ ապրիլ). «Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 313 (1): 176–90. doi:10.1124/jpet.104.078402. PMID 15608077.
Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (1998 թ․ նոյեմբեր). «Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 658–66. PMID 9808693. Արխիվացված է օրիգինալից 2020 թ․ մայիսի 2-ին. Վերցված է 2020 թ․ հունվարի 29-ին.

consumerhealthchoices.org

Consumer Reports (2013), Using Antihistamines to Treat Allergies, Hay Fever, & Hives - Comparing Effectiveness, Safety, and Price (PDF), Yonkers, New York: Consumer Reports, Արխիվացված է օրիգինալից (PDF) 2017 թ․ մայիսի 17-ին, Վերցված է 2017 թ․ հունիսի 29-ին {{citation}}: More than one of |archivedate= and |archive-date= specified (օգնություն); More than one of |archiveurl= and |archive-url= specified (օգնություն)

doi.org

Canonica GW, Blaiss M (2011). «Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J. 4 (2): 47–53. doi:10.1097/WOX.0b013e3182093e19. PMC 3500039. PMID 23268457. «The H1-receptor is a transmembrane protein belonging to the G-protein coupled receptor family. Signal transduction from the extracellular to the intracellular environment occurs as the GCPR becomes activated after binding of a specific ligand or agonist. A subunit of the G-protein subsequently dissociates and affects intracellular messaging including downstream signaling accomplished through various intermediaries such as cyclic AMP, cyclic GMP, calcium, and nuclear factor kappa B (NF-κB), a ubiquitous transcription factor thought to play an important role in immune-cell chemotaxis, proinflammatory cytokine production, expression of cell adhesion molecules, and other allergic and inflammatory conditions.1,8,12,30–32 ... For example, the H1-receptor promotes NF-κB in both a constitutive and agonist-dependent manner and all clinically available H1-antihistamines inhibit constitutive H1-receptor-mediated NF-κB production ...
Importantly, because antihistamines can theoretically behave as inverse agonists or neutral antagonists, they are more properly described as H1-antihistamines rather than H1-receptor antagonists.15»
Panula P, Chazot PL, Cowart M, և այլք: (2015). «International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors». Pharmacol. Rev. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Leurs R, Church MK, Taglialatela M (2002 թ․ ապրիլ). «H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects». Clinical and Experimental Allergy. 32 (4): 489–98. doi:10.1046/j.0954-7894.2002.01314.x. PMID 11972592.
Monroe EW, Daly AF, Shalhoub RF (1997 թ․ փետրվար). «Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines». The Journal of Allergy and Clinical Immunology. 99 (2): S798–806. doi:10.1016/s0091-6749(97)70128-3. PMID 9042073.
Lee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M (2014). «Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study». J Eur Acad Dermatol Venereol. 28 (12): 1654–60. doi:10.1111/jdv.12403. PMID 25081735.
Layton AM (2016). «Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris». Dermatol Clin. 34 (2): 147–57. doi:10.1016/j.det.2015.11.008. PMID 27015774.
Yoneyama H, և այլք: (2008 թ․ մարտ). «Efficient approaches to S-alkyl-N-alkylisothioureas: syntheses of histamine H3 antagonist clobenpropit and its analogues». The Journal of Organic Chemistry. 73 (6): 2096–104. doi:10.1021/jo702181x. PMID 18278935.
Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005 թ․ ապրիլ). «Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 313 (1): 176–90. doi:10.1124/jpet.104.078402. PMID 15608077.
Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA (2004 թ․ սեպտեմբեր). «Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist». Biochemical Pharmacology. 68 (5): 933–45. doi:10.1016/j.bcp.2004.05.048. PMID 15294456.
Ostrom, NK (2014). «The history and progression of treatments for allergic rhinitis». Allergy and Asthma Proceedings. 35 Suppl 1 (3): S3–10. doi:10.2500/aap.2014.35.3758. PMID 25582156.
Jones, AW (2016 թ․ հունվար). «Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists». Clinical Pharmacology in Drug Development. 5 (1): 5–12. doi:10.1002/cpdd.236. PMID 27119574.

drugs.com

«Drug Interaction Report». drugs.com. Վերցված է 2017 թ․ հունվարի 28-ին.

guidetopharmacology.org

«H1 receptor». IUPHAR/BPS Guide to Pharmacology. Վերցված է 2015 թ․ հոկտեմբերի 8-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Canonica GW, Blaiss M (2011). «Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J. 4 (2): 47–53. doi:10.1097/WOX.0b013e3182093e19. PMC 3500039. PMID 23268457. «The H1-receptor is a transmembrane protein belonging to the G-protein coupled receptor family. Signal transduction from the extracellular to the intracellular environment occurs as the GCPR becomes activated after binding of a specific ligand or agonist. A subunit of the G-protein subsequently dissociates and affects intracellular messaging including downstream signaling accomplished through various intermediaries such as cyclic AMP, cyclic GMP, calcium, and nuclear factor kappa B (NF-κB), a ubiquitous transcription factor thought to play an important role in immune-cell chemotaxis, proinflammatory cytokine production, expression of cell adhesion molecules, and other allergic and inflammatory conditions.1,8,12,30–32 ... For example, the H1-receptor promotes NF-κB in both a constitutive and agonist-dependent manner and all clinically available H1-antihistamines inhibit constitutive H1-receptor-mediated NF-κB production ...
Importantly, because antihistamines can theoretically behave as inverse agonists or neutral antagonists, they are more properly described as H1-antihistamines rather than H1-receptor antagonists.15»
Panula P, Chazot PL, Cowart M, և այլք: (2015). «International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors». Pharmacol. Rev. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Leurs R, Church MK, Taglialatela M (2002 թ․ ապրիլ). «H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects». Clinical and Experimental Allergy. 32 (4): 489–98. doi:10.1046/j.0954-7894.2002.01314.x. PMID 11972592.
Norrby K (1995). «Evidence of a dual role of endogenous histamine in angiogenesis». Int J Exp Pathol. 76 (2): 87–92. PMC 1997159. PMID 7540412.
Monroe EW, Daly AF, Shalhoub RF (1997 թ․ փետրվար). «Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines». The Journal of Allergy and Clinical Immunology. 99 (2): S798–806. doi:10.1016/s0091-6749(97)70128-3. PMID 9042073.
Lee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M (2014). «Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study». J Eur Acad Dermatol Venereol. 28 (12): 1654–60. doi:10.1111/jdv.12403. PMID 25081735.
Layton AM (2016). «Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris». Dermatol Clin. 34 (2): 147–57. doi:10.1016/j.det.2015.11.008. PMID 27015774.
Yoneyama H, և այլք: (2008 թ․ մարտ). «Efficient approaches to S-alkyl-N-alkylisothioureas: syntheses of histamine H3 antagonist clobenpropit and its analogues». The Journal of Organic Chemistry. 73 (6): 2096–104. doi:10.1021/jo702181x. PMID 18278935.
Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005 թ․ ապրիլ). «Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 313 (1): 176–90. doi:10.1124/jpet.104.078402. PMID 15608077.
Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (1998 թ․ նոյեմբեր). «Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 658–66. PMID 9808693. Արխիվացված է օրիգինալից 2020 թ․ մայիսի 2-ին. Վերցված է 2020 թ․ հունվարի 29-ին.
Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA (2004 թ․ սեպտեմբեր). «Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist». Biochemical Pharmacology. 68 (5): 933–45. doi:10.1016/j.bcp.2004.05.048. PMID 15294456.
Ostrom, NK (2014). «The history and progression of treatments for allergic rhinitis». Allergy and Asthma Proceedings. 35 Suppl 1 (3): S3–10. doi:10.2500/aap.2014.35.3758. PMID 25582156.
Jones, AW (2016 թ․ հունվար). «Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists». Clinical Pharmacology in Drug Development. 5 (1): 5–12. doi:10.1002/cpdd.236. PMID 27119574.

ncbi.nlm.nih.gov

Canonica GW, Blaiss M (2011). «Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J. 4 (2): 47–53. doi:10.1097/WOX.0b013e3182093e19. PMC 3500039. PMID 23268457. «The H1-receptor is a transmembrane protein belonging to the G-protein coupled receptor family. Signal transduction from the extracellular to the intracellular environment occurs as the GCPR becomes activated after binding of a specific ligand or agonist. A subunit of the G-protein subsequently dissociates and affects intracellular messaging including downstream signaling accomplished through various intermediaries such as cyclic AMP, cyclic GMP, calcium, and nuclear factor kappa B (NF-κB), a ubiquitous transcription factor thought to play an important role in immune-cell chemotaxis, proinflammatory cytokine production, expression of cell adhesion molecules, and other allergic and inflammatory conditions.1,8,12,30–32 ... For example, the H1-receptor promotes NF-κB in both a constitutive and agonist-dependent manner and all clinically available H1-antihistamines inhibit constitutive H1-receptor-mediated NF-κB production ...
Importantly, because antihistamines can theoretically behave as inverse agonists or neutral antagonists, they are more properly described as H1-antihistamines rather than H1-receptor antagonists.15»
Panula P, Chazot PL, Cowart M, և այլք: (2015). «International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors». Pharmacol. Rev. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Norrby K (1995). «Evidence of a dual role of endogenous histamine in angiogenesis». Int J Exp Pathol. 76 (2): 87–92. PMC 1997159. PMID 7540412.

web.archive.org

Consumer Reports (2013), Using Antihistamines to Treat Allergies, Hay Fever, & Hives - Comparing Effectiveness, Safety, and Price (PDF), Yonkers, New York: Consumer Reports, Արխիվացված է օրիգինալից (PDF) 2017 թ․ մայիսի 17-ին, Վերցված է 2017 թ․ հունիսի 29-ին {{citation}}: More than one of |archivedate= and |archive-date= specified (օգնություն); More than one of |archiveurl= and |archive-url= specified (օգնություն)
Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (1998 թ․ նոյեմբեր). «Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist». The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 658–66. PMID 9808693. Արխիվացված է օրիգինալից 2020 թ․ մայիսի 2-ին. Վերցված է 2020 թ․ հունվարի 29-ին.